March 27, 2014Current Medical Research and Opinion
Postprandial lipemia as a cardiometabolic risk factor
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
May support postprandial lipemia as a CAD therapeutic target; hypothesis-generating and requires randomized trials before practice change.
Key Points
- To evaluate the impact of postprandial lipemia and triglyceride-rich lipoprotein dynamics on cardiometabolic health and cardiovascular disease risk.
- Synthesized mechanistic and clinical evidence evaluating postprandial lipid metabolism and triglyceride-rich lipoprotein clearance.
- Assessed dietary, physiological, pathological, and genetic factors influencing post-meal lipid concentrations across metabolic and cardiovascular diseases.
- Individuals with coronary heart disease, type 2 diabetes, insulin resistance, and obesity exhibit heightened postprandial triglyceride excursions compared to healthy controls.
- Impaired clearance of chylomicrons, very low density lipoproteins, and their remnants manifests even in patients presenting with normal fasting triglyceride levels.
- Abnormal postprandial lipoprotein metabolism directly contributes to coronary artery disease pathogenesis, indicating that targeted lifestyle and pharmacological interventions reduce cardiovascular risk.
Cite This Study
Pirillo et al. (2014) studied this question.